• Maria Soloveychik on synthetic biology for discovery of protein interaction modulators

  • Nov 7 2024
  • Durée: 59 min
  • Podcast

Maria Soloveychik on synthetic biology for discovery of protein interaction modulators

  • Résumé

  • Maria Soloveychik is the co-founder and CEO of SyntheX, a therapeutics company accelerating drug discovery through synthetic biology. SyntheX, founded in 2016 and headquartered in San Francisco, advances its own oncology pipeline and partners in external discovery collaborations. Maria holds a PhD in Molecular Genetics from the University of Toronto, where her research uncovered novel pathways linking metabolism and epigenetic signaling. As a former research scientist at the Structural Genomics Consortium, her work contributed to determining numerous protein structures and identifying several promising drug candidates.

    Voir plus Voir moins

Ce que les auditeurs disent de Maria Soloveychik on synthetic biology for discovery of protein interaction modulators

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.